These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22178961)

  • 1. The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment.
    Majhail NS; Murphy EA; Denzen EM; Ferguson SS; Anasetti C; Bracey A; Burns L; Champlin R; Hubbard N; Markowitz M; Maziarz RT; Medoff E; Neumann J; Schmit-Pokorny K; Weisdorf DJ; Yolin Raley DS; Chell J; Snyder EL
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):172-82. PubMed ID: 22178961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.
    Burns LJ; Gajewski JL; Majhail NS; Navarro W; Perales MA; Shereck E; Selby GB; Snyder EL; Woolfrey AE; Litzow MR
    Biol Blood Marrow Transplant; 2014 May; 20(5):617-21. PubMed ID: 24508838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.
    Denzen EM; Majhail NS; Stickney Ferguson S; Anasetti C; Bracey A; Burns L; Champlin R; Chell J; Leather H; Lill M; Maziarz RT; Medoff E; Neumann J; Schmit-Pokorny K; Snyder EL; Wiggins L; Yolin Raley DS; Murphy EA
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):4-11. PubMed ID: 23078785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation.
    Murphy EA; Ferguson SS; Omondi NA; Getzendaner LC; Gajewski JL; Goldstein GA; Wingard JR; Rizzo JD; Majhail NS
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):147-56. PubMed ID: 20142045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.
    Pidala J; Mupfudze TG; Payton T; Barker J; Perales MA; Shaw BE; Fernández-Viña M; Burns LJ; Dehn J
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2501-2506. PubMed ID: 31419569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem.
    Auletta JJ; Sandmaier BM; Jensen E; Majhail NS; Knutson J; Nemecek E; Ajayi-Hackworth F; Davies SM;
    Transplant Cell Ther; 2022 Dec; 28(12):802-809. PubMed ID: 36184058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop.
    Auletta JJ; Holter-Chakrabarty J; Jain T; Miller B; Ward E; Khera N; Gomez-Arteaga A; Hall A; Nemecek E; Robb D; Yusuf RA; Davies SM;
    Transplant Cell Ther; 2023 Dec; 29(12):739-746. PubMed ID: 37805142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative.
    Auletta JJ; Khera N; DeMartino P; Kelkar AH; Yusuf RA; Davies SM; Knutson J; Beaver E; Maloney A; Majhail NS
    Transplant Cell Ther; 2023 Nov; 29(11):713-720. PubMed ID: 37579920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Marrow Donor Program: improving access to hematopoietic cell transplantation.
    Walker T; Milford E; Chell J; Maiers M; Confer D
    Clin Transpl; 2011; ():55-62. PubMed ID: 22755401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program.
    Karanes C; Confer D; Walker T; Askren A; Keller C
    Oncology (Williston Park); 2003 Aug; 17(8):1036-8, 1043-4, 1164-7. PubMed ID: 12966671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic transplant physician and center capacity in the United States.
    Majhail NS; Murphy EA; Omondi NA; Robinett P; Gajewski JL; LeMaistre CF; Confer D; Rizzo JD
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):956-61. PubMed ID: 21540121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
    Dodson KL; Coppo PA; Confer DL
    Clin Transpl; 1999; ():121-7. PubMed ID: 11038630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
    Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.
    Majhail NS; Mau LW; Chitphakdithai P; Payton T; Eckrich M; Joffe S; Lee SJ; LeMaistre CF; LeRademacher J; Loberiza F; Logan B; Parsons SK; Repaczki-Jones R; Robinett P; Rizzo JD; Murphy E; Denzen EM
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1308-14. PubMed ID: 25840337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors.
    Johansen KA; Schneider JF; McCaffree MA; Woods GL;
    Transfus Med; 2008 Aug; 18(4):250-9. PubMed ID: 18783584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
    MacMillan ML; Davies SM; Nelson GO; Chitphakdithai P; Confer DL; King RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):16-22. PubMed ID: 18721776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers.
    Foster J; Moore H; Preussler JM; Burns LJ; Umar JH; Glotzbecker B; Johnson S; MacDougall H; Mau LW; Murphy EA; Ustun C; Ferguson SS; Denzen E
    J Cancer Educ; 2020 Aug; 35(4):651-660. PubMed ID: 30877651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived Workforce Challenges among Clinical Social Workers in Hematopoietic Cell Transplantation Programs.
    Stickney Ferguson S; Randall J; Dabney J; Kalbacker ME; Boyle N; Thao V; Murphy EA; Denzen EM
    Biol Blood Marrow Transplant; 2018 May; 24(5):1063-1068. PubMed ID: 29288820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation.
    Confer D; Robinett P
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S3-S5. PubMed ID: 18724295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.